Imino(methyl)(4-methylphenyl)-lambda6-sulfanone, 98%, 250mg

N'-(4,6-difluoro-1,3-benzothiazol-2-yl)-N,N-diethylethane-1,2-diamine, 95.0%, 250mg

2-(Benzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

MANT-M3GN2-DNP>98.0%(HPLC)1mg

2-(3-Chlorophenyl)malondialdehyde, 95.0%, 1g

Fmoc-Lys(Boc)-OH, 98%, 25g

3-Bromo-4-hydroxy-5-methoxybenzaldehyde, 95.0%, 25g

3-Methyl-5-nitrobenzo[d]isoxazole, 97%, 10g

N,N-diisopropiletilamina (DIPEA), 250 ml, >=99,5 %, para síntesis de péptidos, envase de vidrio

2-(Trifluoromethyl)pyridin-3-amine, 95.0%, 25g

2-Bromo-11H-benzo[b]fluoren-11-one, 98.0%, 1g

4-(4-Bromophenoxy)benzaldehyde>98.0%(GC)1g

1-BOC-6-OXO-1-AZASPIRO[3.3]HEPTANE, 95.0%, 250mg